Early treatment to help premature babies' lungs grow
Treatments studied
Part of Lungs & breathing, Women’s health & pregnancy clinical trials.
This study tests an experimental treatment to help premature babies' lungs grow stronger and reduce the need for a breathing machine. It might help your baby if they are very premature and still need extra oxygen and breathing support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born between 22 weeks and 28 weeks 6 days of pregnancy (very premature).
- Your baby is now 7 to 14 days old.
- Your baby needs a breathing machine (ventilator) and extra oxygen (at least 30% oxygen).
- Your baby does not have major birth defects, recent bleeding in the lungs, or an active infection.
- You (the birth parent) are at least 18 years old and can give permission in English or Spanish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way of setting the ventilator for preterm babies born before 34 weeks who are still on a breathing machine. It aims to improve lung healing and heart function by finding the best pressure settings. The results could help your baby breathe more comfortably.
This study tests whether a special cell therapy (MSC-EVs) given to extremely premature babies can help prevent a serious lung disease called bronchopulmonary dysplasia (BPD). The treatment is given while the baby is still on a breathing machine.
This study compares two types of non-invasive breathing support for premature babies who are having trouble breathing due to underdeveloped lungs. The goal is to see which method works better and helps babies breathe comfortably without needing a breathing tube.
This trial tests different ways to help very preterm babies when they are first taken off a breathing machine and switched to CPAP. It aims to find the safest and most effective breathing support to help them breathe on their own.
This study tests a lung medication called pulmonary surfactant, given with different oxygen levels, to help very premature babies (born before 32 weeks) who have breathing difficulties. The goal is to see which oxygen level works best with non-invasive breathing support.
This trial gives a medication called surfactant early (when oxygen needs are slightly increased) to very premature babies with breathing trouble. It aims to see if this early treatment helps them breathe better without needing a breathing tube, potentially improving their outcomes.
Hear when a new Invasive Mechanical Ventilation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.